CanSino Biologics, Inc. (CASBF)
3.90
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
CanSino Biologics Total Liabilities (Quarterly) : 298.95M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 298.95M |
| December 31, 2025 | 288.15M |
| September 30, 2025 | 332.91M |
| June 30, 2025 | 357.45M |
| March 31, 2025 | 402.89M |
| December 31, 2024 | 384.05M |
| September 30, 2024 | 417.06M |
| June 30, 2024 | 398.11M |
| March 31, 2024 | 479.03M |
| December 31, 2023 | 545.03M |
| September 30, 2023 | 521.96M |
| June 30, 2023 | 510.44M |
| March 31, 2023 | 602.07M |
| December 31, 2022 | 575.54M |
| September 30, 2022 | 533.65M |
| Date | Value |
|---|---|
| June 30, 2022 | 528.34M |
| March 31, 2022 | 497.46M |
| December 31, 2021 | 490.30M |
| September 30, 2021 | 536.21M |
| June 30, 2021 | 472.68M |
| March 31, 2021 | 214.90M |
| December 31, 2020 | 77.18M |
| September 30, 2020 | 55.02M |
| June 30, 2020 | 38.80M |
| March 31, 2020 | 40.07M |
| December 31, 2019 | 36.49M |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| June 30, 2018 | 39.55M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.012B |
| Shareholders Equity (Quarterly) | 713.05M |
| Debt to Equity Ratio | 0.2358 |
| Current Ratio | 4.107 |
| Net Debt Paydown Yield | 2.27% |